BVF as of June 30, 2022
Portfolio Holdings for BVF
BVF holds 79 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Repare Therapeutics Ord (RPTX) | 5.6 | $116M | 8.3M | 13.99 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 5.5 | $114M | 22M | 5.25 | |
| Arcus Biosciences Incorporated (RCUS) | 4.8 | $100M | 4.0M | 25.34 | |
| Cullinan Oncology (CGEM) | 4.6 | $96M | 7.5M | 12.82 | |
| Gh Research Ordinary Shares (GHRS) | 4.5 | $93M | 9.3M | 9.98 | |
| Merus N V (MRUS) | 4.5 | $92M | 4.1M | 22.64 | |
| Kymera Therapeutics (KYMR) | 3.9 | $82M | 4.1M | 19.69 | |
| Xoma Corp Del Com New (XOMA) | 3.8 | $79M | 3.5M | 22.28 | |
| Relay Therapeutics (RLAY) | 3.5 | $73M | 4.4M | 16.75 | |
| Crinetics Pharmaceuticals In (CRNX) | 3.3 | $69M | 3.7M | 18.65 | |
| Kura Oncology (KURA) | 2.8 | $59M | 3.2M | 18.33 | |
| Aclaris Therapeutics (ACRS) | 2.7 | $56M | 4.0M | 13.96 | |
| Cti Biopharma | 2.6 | $53M | 8.9M | 5.97 | |
| Eqrx | 2.4 | $50M | 11M | 4.69 | |
| Xenon Pharmaceuticals (XENE) | 2.3 | $49M | 1.6M | 30.42 | |
| Ionis Pharmaceuticals (IONS) | 2.3 | $47M | 1.3M | 37.02 | |
| Syndax Pharmaceuticals (SNDX) | 2.2 | $45M | 2.4M | 19.24 | |
| Revolution Medicines (RVMD) | 2.1 | $44M | 2.3M | 19.49 | |
| Iteos Therapeutics (ITOS) | 1.9 | $40M | 1.9M | 20.60 | |
| Ideaya Biosciences (IDYA) | 1.9 | $39M | 2.8M | 13.80 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.6 | $34M | 6.9M | 4.87 | |
| Relmada Therapeutics (RLMD) | 1.5 | $32M | 1.7M | 18.99 | |
| Cincor Pharma | 1.5 | $31M | 1.6M | 18.84 | |
| Olema Pharmaceuticals (OLMA) | 1.5 | $31M | 7.6M | 4.07 | |
| 4d Molecular Therapeutics In (FDMT) | 1.4 | $28M | 4.0M | 6.98 | |
| Ac Immune Sa SHS (ACIU) | 1.3 | $27M | 7.4M | 3.61 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 1.3 | $26M | 14M | 1.86 | |
| Verastem | 1.1 | $23M | 20M | 1.16 | |
| Point Biopharma Global | 1.1 | $23M | 3.4M | 6.81 | |
| Nuvalent Inc-a (NUVL) | 1.1 | $23M | 1.7M | 13.56 | |
| Cogent Biosciences (COGT) | 1.0 | $20M | 2.3M | 9.02 | |
| Miragen Therapeutics (VRDN) | 1.0 | $20M | 1.7M | 11.57 | |
| Rain Therapeutics | 0.9 | $20M | 3.5M | 5.56 | |
| Sutro Biopharma (STRO) | 0.9 | $18M | 3.4M | 5.21 | |
| Janux Therapeutics (JANX) | 0.9 | $18M | 1.5M | 12.21 | |
| Tyra Biosciences (TYRA) | 0.9 | $18M | 2.5M | 7.15 | |
| Replimune Group (REPL) | 0.8 | $16M | 927k | 17.48 | |
| Concert Pharmaceuticals I equity | 0.7 | $15M | 3.6M | 4.21 | |
| Ovid Therapeutics (OVID) | 0.7 | $15M | 6.9M | 2.15 | |
| Annexon (ANNX) | 0.7 | $14M | 3.8M | 3.77 | |
| Viracta Therapeutics (VIRX) | 0.7 | $14M | 3.6M | 3.88 | |
| Calliditas Therapeutics Ab Sponsered Ads (CALT) | 0.7 | $14M | 750k | 17.97 | |
| 89bio (ETNB) | 0.6 | $13M | 3.9M | 3.22 | |
| An2 Therapeutics (ANTX) | 0.6 | $13M | 1.6M | 7.75 | |
| Contrafect Corp Com New | 0.6 | $12M | 4.0M | 3.07 | |
| Essa Pharma Com New (EPIX) | 0.6 | $12M | 3.7M | 3.15 | |
| Ikena Oncology (IKNA) | 0.5 | $11M | 2.5M | 4.43 | |
| Alpine Immune Sciences (ALPN) | 0.5 | $11M | 1.3M | 8.51 | |
| Aadi Bioscience (AADI) | 0.5 | $11M | 879k | 12.32 | |
| Cytomx Therapeutics (CTMX) | 0.5 | $11M | 5.8M | 1.83 | |
| Generation Bio (GBIO) | 0.5 | $10M | 1.6M | 6.60 | |
| Pieris Pharmaceuticals (PIRS) | 0.5 | $9.5M | 5.1M | 1.87 | |
| Protagonist Therapeutics (PTGX) | 0.4 | $8.8M | 1.1M | 7.91 | |
| Silence Therapeutics Ads (SLN) | 0.4 | $7.9M | 667k | 11.85 | |
| Pyxis Oncology Common Stock (PYXS) | 0.3 | $7.0M | 2.9M | 2.38 | |
| Glycomimetics (GLYC) | 0.3 | $5.7M | 9.5M | 0.60 | |
| Eledon Pharmaceuticals (ELDN) | 0.3 | $5.7M | 2.3M | 2.44 | |
| Molecular Templates | 0.2 | $4.6M | 5.0M | 0.91 | |
| Hillevax (HLVX) | 0.2 | $4.2M | 383k | 10.93 | |
| Celldex Therapeutics Com New (CLDX) | 0.2 | $4.2M | 154k | 26.96 | |
| Infinity Pharmaceuticals (INFIQ) | 0.2 | $4.0M | 6.4M | 0.63 | |
| Inventiva Sa Ads (IVA) | 0.2 | $4.0M | 686k | 5.82 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.2 | $3.4M | 6.9M | 0.49 | |
| Elevation Oncology (ELEV) | 0.2 | $3.2M | 2.3M | 1.40 | |
| Molecular Partners Ads (MOLN) | 0.1 | $3.0M | 443k | 6.73 | |
| Spero Therapeutics (SPRO) | 0.1 | $2.3M | 3.1M | 0.74 | |
| Selecta Biosciences (RNAC) | 0.1 | $2.3M | 1.7M | 1.31 | |
| Forward Pharma A/s Sponsord Ads New | 0.1 | $2.2M | 514k | 4.33 | |
| Mei Pharma Com New | 0.1 | $2.1M | 3.5M | 0.60 | |
| Erytech Pharma Sponsored Adr | 0.1 | $1.4M | 1.3M | 1.10 | |
| Aileron Therapeutics | 0.1 | $1.4M | 5.3M | 0.26 | |
| Corvus Pharmaceuticals (CRVS) | 0.1 | $1.4M | 1.4M | 0.99 | |
| Galmed Pharmaceuticals SHS | 0.1 | $1.2M | 1.8M | 0.68 | |
| Angion Biomedica Corp | 0.1 | $1.2M | 1.1M | 1.14 | |
| Calithera Biosciences Com New (CALA) | 0.1 | $1.1M | 465k | 2.46 | |
| Voyager Therapeutics (VYGR) | 0.0 | $827k | 140k | 5.91 | |
| X4 Pharmaceuticals (XFOR) | 0.0 | $818k | 848k | 0.96 | |
| Rezolute Com New (RZLT) | 0.0 | $616k | 191k | 3.23 | |
| Bionomics Ads (BNOX) | 0.0 | $555k | 81k | 6.85 |
